Nano-bio-chips for high performance multiplexed protein detection: Determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels

Jesse V. Jokerst, Archana Raamanathan, Nicolaos Christodoulides, Pierre N. Floriano, Amanda A. Pollard, Glennon W. Simmons, Jorge Wong, Carole Gage, Wieslaw B. Furmaga, Spencer W. Redding, John McDevitt

Research output: Contribution to journalArticle

Abstract

The integration of semiconductor nanoparticle quantum dots (QDs) into a modular, microfluidic biosensor for the multiplexed quantitation of three important cancer markers, carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and Her-2/Neu (C-erbB-2) was achieved. The functionality of the integrated sample processing, analyte capture and detection modalities was demonstrated using both serum and whole saliva specimens. Here, nano-bio-chips that employed a fluorescence transduction signal with QD-labeled detecting antibody were used in combination with antigen capture by a microporous agarose bead array supported within a microfluidics ensemble so as to complete the sandwich-type immunoassay. The utilization of QD probes in this miniaturized biosensor format resulted in signal amplification 30 times relative to that of standard molecular fluorophores as well as affording a reduction in observed limits of detection by nearly 2 orders of magnitude (0.02 ng/mL CEA; 0.11 pM CEA) relative to enzyme-linked immunosorbent assay (ELISA). Assay validation studies indicate that measurements by the nano-bio-chip system correlate to standard methods at R2 = 0.94 and R2 = 0.95 for saliva and serum, respectively. This integrated nano-bio-chip assay system, in tandem with next-generation fluorophores, promises to be a sensitive, multiplexed tool for important diagnostic and prognostic applications.

Original languageEnglish (US)
Pages (from-to)3622-3629
Number of pages8
JournalBiosensors and Bioelectronics
Volume24
Issue number12
DOIs
StatePublished - Aug 15 2009

Fingerprint

Quantum Dots
Carcinoembryonic Antigen
Antigens
Tumor Biomarkers
Saliva
Semiconductor quantum dots
Labels
Assays
Fluorophores
Proteins
Microfluidics
Biosensors
Biosensing Techniques
Serum
Signal transduction
Immunosorbents
Sepharose
Amplification
Validation Studies
Differentiation Antigens

Keywords

  • Cancer biomarkers
  • Lab-on-a-chip
  • Nano-bio-chip
  • Point-of-care
  • Quantum dots
  • Salivary diagnostics

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Biotechnology
  • Electrochemistry

Cite this

Nano-bio-chips for high performance multiplexed protein detection : Determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. / Jokerst, Jesse V.; Raamanathan, Archana; Christodoulides, Nicolaos; Floriano, Pierre N.; Pollard, Amanda A.; Simmons, Glennon W.; Wong, Jorge; Gage, Carole; Furmaga, Wieslaw B.; Redding, Spencer W.; McDevitt, John.

In: Biosensors and Bioelectronics, Vol. 24, No. 12, 15.08.2009, p. 3622-3629.

Research output: Contribution to journalArticle

Jokerst, JV, Raamanathan, A, Christodoulides, N, Floriano, PN, Pollard, AA, Simmons, GW, Wong, J, Gage, C, Furmaga, WB, Redding, SW & McDevitt, J 2009, 'Nano-bio-chips for high performance multiplexed protein detection: Determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels', Biosensors and Bioelectronics, vol. 24, no. 12, pp. 3622-3629. https://doi.org/10.1016/j.bios.2009.05.026
Jokerst, Jesse V. ; Raamanathan, Archana ; Christodoulides, Nicolaos ; Floriano, Pierre N. ; Pollard, Amanda A. ; Simmons, Glennon W. ; Wong, Jorge ; Gage, Carole ; Furmaga, Wieslaw B. ; Redding, Spencer W. ; McDevitt, John. / Nano-bio-chips for high performance multiplexed protein detection : Determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. In: Biosensors and Bioelectronics. 2009 ; Vol. 24, No. 12. pp. 3622-3629.
@article{cb8c1aec84cc49528627e463a084317c,
title = "Nano-bio-chips for high performance multiplexed protein detection: Determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels",
abstract = "The integration of semiconductor nanoparticle quantum dots (QDs) into a modular, microfluidic biosensor for the multiplexed quantitation of three important cancer markers, carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and Her-2/Neu (C-erbB-2) was achieved. The functionality of the integrated sample processing, analyte capture and detection modalities was demonstrated using both serum and whole saliva specimens. Here, nano-bio-chips that employed a fluorescence transduction signal with QD-labeled detecting antibody were used in combination with antigen capture by a microporous agarose bead array supported within a microfluidics ensemble so as to complete the sandwich-type immunoassay. The utilization of QD probes in this miniaturized biosensor format resulted in signal amplification 30 times relative to that of standard molecular fluorophores as well as affording a reduction in observed limits of detection by nearly 2 orders of magnitude (0.02 ng/mL CEA; 0.11 pM CEA) relative to enzyme-linked immunosorbent assay (ELISA). Assay validation studies indicate that measurements by the nano-bio-chip system correlate to standard methods at R2 = 0.94 and R2 = 0.95 for saliva and serum, respectively. This integrated nano-bio-chip assay system, in tandem with next-generation fluorophores, promises to be a sensitive, multiplexed tool for important diagnostic and prognostic applications.",
keywords = "Cancer biomarkers, Lab-on-a-chip, Nano-bio-chip, Point-of-care, Quantum dots, Salivary diagnostics",
author = "Jokerst, {Jesse V.} and Archana Raamanathan and Nicolaos Christodoulides and Floriano, {Pierre N.} and Pollard, {Amanda A.} and Simmons, {Glennon W.} and Jorge Wong and Carole Gage and Furmaga, {Wieslaw B.} and Redding, {Spencer W.} and John McDevitt",
year = "2009",
month = "8",
day = "15",
doi = "10.1016/j.bios.2009.05.026",
language = "English (US)",
volume = "24",
pages = "3622--3629",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - Nano-bio-chips for high performance multiplexed protein detection

T2 - Determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels

AU - Jokerst, Jesse V.

AU - Raamanathan, Archana

AU - Christodoulides, Nicolaos

AU - Floriano, Pierre N.

AU - Pollard, Amanda A.

AU - Simmons, Glennon W.

AU - Wong, Jorge

AU - Gage, Carole

AU - Furmaga, Wieslaw B.

AU - Redding, Spencer W.

AU - McDevitt, John

PY - 2009/8/15

Y1 - 2009/8/15

N2 - The integration of semiconductor nanoparticle quantum dots (QDs) into a modular, microfluidic biosensor for the multiplexed quantitation of three important cancer markers, carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and Her-2/Neu (C-erbB-2) was achieved. The functionality of the integrated sample processing, analyte capture and detection modalities was demonstrated using both serum and whole saliva specimens. Here, nano-bio-chips that employed a fluorescence transduction signal with QD-labeled detecting antibody were used in combination with antigen capture by a microporous agarose bead array supported within a microfluidics ensemble so as to complete the sandwich-type immunoassay. The utilization of QD probes in this miniaturized biosensor format resulted in signal amplification 30 times relative to that of standard molecular fluorophores as well as affording a reduction in observed limits of detection by nearly 2 orders of magnitude (0.02 ng/mL CEA; 0.11 pM CEA) relative to enzyme-linked immunosorbent assay (ELISA). Assay validation studies indicate that measurements by the nano-bio-chip system correlate to standard methods at R2 = 0.94 and R2 = 0.95 for saliva and serum, respectively. This integrated nano-bio-chip assay system, in tandem with next-generation fluorophores, promises to be a sensitive, multiplexed tool for important diagnostic and prognostic applications.

AB - The integration of semiconductor nanoparticle quantum dots (QDs) into a modular, microfluidic biosensor for the multiplexed quantitation of three important cancer markers, carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and Her-2/Neu (C-erbB-2) was achieved. The functionality of the integrated sample processing, analyte capture and detection modalities was demonstrated using both serum and whole saliva specimens. Here, nano-bio-chips that employed a fluorescence transduction signal with QD-labeled detecting antibody were used in combination with antigen capture by a microporous agarose bead array supported within a microfluidics ensemble so as to complete the sandwich-type immunoassay. The utilization of QD probes in this miniaturized biosensor format resulted in signal amplification 30 times relative to that of standard molecular fluorophores as well as affording a reduction in observed limits of detection by nearly 2 orders of magnitude (0.02 ng/mL CEA; 0.11 pM CEA) relative to enzyme-linked immunosorbent assay (ELISA). Assay validation studies indicate that measurements by the nano-bio-chip system correlate to standard methods at R2 = 0.94 and R2 = 0.95 for saliva and serum, respectively. This integrated nano-bio-chip assay system, in tandem with next-generation fluorophores, promises to be a sensitive, multiplexed tool for important diagnostic and prognostic applications.

KW - Cancer biomarkers

KW - Lab-on-a-chip

KW - Nano-bio-chip

KW - Point-of-care

KW - Quantum dots

KW - Salivary diagnostics

UR - http://www.scopus.com/inward/record.url?scp=67650034253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650034253&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2009.05.026

DO - 10.1016/j.bios.2009.05.026

M3 - Article

C2 - 19576756

AN - SCOPUS:67650034253

VL - 24

SP - 3622

EP - 3629

JO - Biosensors

JF - Biosensors

SN - 0956-5663

IS - 12

ER -